https://www.selleckchem.com/products/pt2977.html
Clinicians frequently order urine drug testing (UDT) for patients on chronic opioid therapy (COT), yet often have difficulty interpreting test results accurately. To evaluate the implementation and effectiveness of a laboratory-generated urine toxicology interpretation service for clinicians prescribing COT. Type II hybrid-convergent mixed methods design (implementation) and pre-post prospective cohort study with matched controls (effectiveness). Four ambulatory sites (2 primary care, 1 pain management, 1 palliative care) within 2 US aca
Like
Comment
Share
